Clinical Trials Browser

INDUSTRY × Adenocarcinoma × folfirinox × Clear all

NCT04990037 2023-06-29

CAPAFOUR

Phase 1 Completed

Gastrointestinal

Adenocarcinoma, Carcinoma, Neoplasm Metastasis, Pancreatic Neoplasms